| http://dbpedia.org/ontology/abstract
|
A Vaxart, Inc. é uma empresa americana de … A Vaxart, Inc. é uma empresa americana de biotecnologia focada na descoberta, desenvolvimento e comercialização de vacinas orais recombinantes administradas usando comprimidos estáveis à temperatura que podem ser armazenados e transportados sem refrigeração, eliminando a necessidade de injeção de agulhas. Seus programas de desenvolvimento para entrega de vacinas orais (chamados VAAST TM ) incluem vacinas profiláticas para comprimidos entéricos revestidos para inibir norovírus, influenza sazonal, vírus sincicial respiratório e papilomavírus humano . Em 2019-20, a Vaxart iniciou um programa para desenvolver uma vacina oral em comprimidos para o coronavírus de 2019, COVID-19, possui um programa de desenvolvimento colaborativo para a entrega oral de uma vacina contra a gripe universal usando antígenos proprietários da Janssen Pharmaceutica (Janssen Vaccines and Prevention BV )tica (Janssen Vaccines and Prevention BV )
, Vaxart, Inc. is an American biotechnology … Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery (Vector-Adjuvant-Antigen Standardized Technology known as VAAST) include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker. Vaxart has a collaborative development program for oral delivery of a vaccine against universal flu using proprietary antigens from Janssen Pharmaceutica (Janssen Vaccines and Prevention B.V.).ca (Janssen Vaccines and Prevention B.V.).
, فاكسارت (بالإنجليزية: vaxart) هي شركة تكنو … فاكسارت (بالإنجليزية: vaxart) هي شركة تكنولوجيا حيوية أمريكية تركز على اكتشاف وتطوير وتسويق اللقاحات التي يتم تناولها عن طريق الفم باستخدام أقراص ثابتة بدرجة الحرارة والتي يمكن تخزينها وشحنها بدون تبريد، مما يلغي الحاجة إلى الحقن بالإبرة. تشمل برامج تطويرها لإيصال اللقاح عن طريق الفم (تسمى VAAST) لقاحات قرصية معوية مغلفة تعمل على تثبيط نوروفيروس (بالإنجليزية: Norovirus)، الإنفلونزا الموسمية (بالإنجليزية: seasonal influenza)، والفيروس المخلوي التنفسي (بالإنجليزية: respiratory syncytial virus)، وفيروس الورم الحليمي البشري (بالإنجليزية: human papillomavirus). لدى فاكسارت برنامج تطوير تعاوني لإيصال لقاح عن طريق الفم ضد الأنفلونزا الشاملة باستخدام مضادات مسجلة الملكية من يانسن فارماسيوتيكا (بالإنجليزية: Janssen Vaccines and Prevention B.V).زية: Janssen Vaccines and Prevention B.V).
|
| http://dbpedia.org/ontology/foundingYear
|
2004
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/South_San_Francisco%2C_California +
|
| http://dbpedia.org/ontology/netIncome
|
7.05E7
|
| http://dbpedia.org/ontology/numberOfEmployees
|
110
|
| http://dbpedia.org/ontology/revenue
|
892000.0
|
| http://dbpedia.org/ontology/revenueYear
|
2021
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Vaxart_Corporate_2022_Logo.png?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageID
|
63256201
|
| http://dbpedia.org/ontology/wikiPageLength
|
12485
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1119172949
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Intramuscular +
, http://dbpedia.org/resource/Infectious_disease +
, http://dbpedia.org/resource/Category:Vaccine_producers +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Prophylactic +
, http://dbpedia.org/resource/Category:COVID-19_vaccine_producers +
, http://dbpedia.org/resource/Immune_response +
, http://dbpedia.org/resource/Severe_acute_respiratory_syndrome%E2%80%93related_coronavirus +
, http://dbpedia.org/resource/2009_flu_pandemic_vaccine +
, http://dbpedia.org/resource/Coronavirus_disease_2019 +
, http://dbpedia.org/resource/Polio +
, http://dbpedia.org/resource/Operation_Warp_Speed +
, http://dbpedia.org/resource/Tablet_%28pharmacy%29 +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Vaccine +
, http://dbpedia.org/resource/COVID-19_pandemic +
, http://dbpedia.org/resource/Securities_Exchange_Commission +
, http://dbpedia.org/resource/Janssen_Pharmaceutica +
, http://dbpedia.org/resource/Recombinant_vaccine +
, http://dbpedia.org/resource/Enteric-coated +
, http://dbpedia.org/resource/Polio_vaccine +
, http://dbpedia.org/resource/Small_intestine +
, http://dbpedia.org/resource/Adenovirus +
, http://dbpedia.org/resource/Seasonal_influenza +
, http://dbpedia.org/resource/Moderna +
, http://dbpedia.org/resource/Novavax +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Francisco +
, http://dbpedia.org/resource/Vector_%28molecular_biology%29 +
, http://dbpedia.org/resource/Immunization +
, http://dbpedia.org/resource/Inovio_Pharmaceuticals +
, http://dbpedia.org/resource/Respiratory_syncytial_virus +
, http://dbpedia.org/resource/Norovirus +
, http://dbpedia.org/resource/Mucosa +
, http://dbpedia.org/resource/Gene +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1982 +
, http://dbpedia.org/resource/Fear_of_needles +
, http://dbpedia.org/resource/Proof_of_concept +
, http://dbpedia.org/resource/Antibody +
, http://dbpedia.org/resource/Category:Medical_research +
, http://dbpedia.org/resource/Systemic_circulation +
, http://dbpedia.org/resource/Antigen +
, http://dbpedia.org/resource/Epithelial_cell +
, http://dbpedia.org/resource/Category:Specialty_drugs +
, http://dbpedia.org/resource/Immune_system +
, http://dbpedia.org/resource/Seasonal_influenza_vaccine_brands +
, http://dbpedia.org/resource/South_San_Francisco%2C_California +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Respiratory_disease +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1982 +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Hedge_fund +
, http://dbpedia.org/resource/Human_papillomavirus +
, http://dbpedia.org/resource/Gastric_acid +
, http://dbpedia.org/resource/Viral_shedding +
|
| http://dbpedia.org/property/foundation
|
2004
|
| http://dbpedia.org/property/founder
|
Sean Tucker
|
| http://dbpedia.org/property/imageCaption
|
Vaxart's HQ located in South San Francisco
|
| http://dbpedia.org/property/imageSize
|
230
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Andrei "Andy" Floroiu
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/South_San_Francisco%2C_California +
|
| http://dbpedia.org/property/logo
|
Vaxart Corporate 2022 Logo.png
|
| http://dbpedia.org/property/name
|
Vaxart, Inc.
|
| http://dbpedia.org/property/netIncome
|
–US$70.5 million
|
| http://dbpedia.org/property/netIncomeYear
|
2021
|
| http://dbpedia.org/property/numEmployees
|
110
|
| http://dbpedia.org/property/numEmployeesYear
|
2021
|
| http://dbpedia.org/property/products
|
Oral vaccines
|
| http://dbpedia.org/property/revenue
|
892000.0
|
| http://dbpedia.org/property/revenueYear
|
2021
|
| http://dbpedia.org/property/tradedAs
|
NASDAQ:VXRT
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Main_article +
, http://dbpedia.org/resource/Template:URL +
, http://dbpedia.org/resource/Template:Decrease +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1982 +
, http://dbpedia.org/resource/Category:Specialty_drugs +
, http://dbpedia.org/resource/Category:Medical_research +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Francisco +
, http://dbpedia.org/resource/Category:Vaccine_producers +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1982 +
, http://dbpedia.org/resource/Category:COVID-19_vaccine_producers +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Vaxart?oldid=1119172949&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/VaxartHQ.jpg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Vaxart_Corporate_2022_Logo.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Vaxart +
|
| http://xmlns.com/foaf/0.1/name
|
Vaxart, Inc.
|
| owl:sameAs |
http://ml.dbpedia.org/resource/%E0%B4%B5%E0%B4%BE%E0%B4%95%E0%B5%8D%E0%B4%B8%E0%B5%8D%E2%80%8D%E0%B4%86%E0%B5%BC%E0%B4%9F%E0%B5%8D%E0%B4%9F%E0%B5%8D +
, http://dbpedia.org/resource/Vaxart +
, http://fa.dbpedia.org/resource/%D9%88%D8%A7%DA%A9%D8%B3%D8%A7%D8%B1%D8%AA +
, http://pt.dbpedia.org/resource/Vaxart +
, https://global.dbpedia.org/id/2ohyU +
, http://www.wikidata.org/entity/Q30292482 +
, http://ar.dbpedia.org/resource/%D9%81%D8%A7%D9%83%D8%B3%D8%A7%D8%B1%D8%AA +
|
| rdf:type |
http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/ontology/Company +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Agent +
|
| rdfs:comment |
فاكسارت (بالإنجليزية: vaxart) هي شركة تكنو … فاكسارت (بالإنجليزية: vaxart) هي شركة تكنولوجيا حيوية أمريكية تركز على اكتشاف وتطوير وتسويق اللقاحات التي يتم تناولها عن طريق الفم باستخدام أقراص ثابتة بدرجة الحرارة والتي يمكن تخزينها وشحنها بدون تبريد، مما يلغي الحاجة إلى الحقن بالإبرة. تشمل برامج تطويرها لإيصال اللقاح عن طريق الفم (تسمى VAAST) لقاحات قرصية معوية مغلفة تعمل على تثبيط نوروفيروس (بالإنجليزية: Norovirus)، الإنفلونزا الموسمية (بالإنجليزية: seasonal influenza)، والفيروس المخلوي التنفسي (بالإنجليزية: respiratory syncytial virus)، وفيروس الورم الحليمي البشري (بالإنجليزية: human papillomavirus).لبشري (بالإنجليزية: human papillomavirus).
, A Vaxart, Inc. é uma empresa americana de … A Vaxart, Inc. é uma empresa americana de biotecnologia focada na descoberta, desenvolvimento e comercialização de vacinas orais recombinantes administradas usando comprimidos estáveis à temperatura que podem ser armazenados e transportados sem refrigeração, eliminando a necessidade de injeção de agulhas. Seus programas de desenvolvimento para entrega de vacinas orais (chamados VAAST TM ) incluem vacinas profiláticas para comprimidos entéricos revestidos para inibir norovírus, influenza sazonal, vírus sincicial respiratório e papilomavírus humano . Em 2019-20, a Vaxart iniciou um programa para desenvolver uma vacina oral em comprimidos para o coronavírus de 2019, COVID-19, possui um programa de desenvolvimento colaborativo para a entrega oral de uma vacina contra a gripe universal usando aa vacina contra a gripe universal usando a
, Vaxart, Inc. is an American biotechnology … Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery (Vector-Adjuvant-Antigen Standardized Technology known as VAAST) include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker.us. It was founded in 2004 by Sean Tucker.
|
| rdfs:label |
Vaxart
, فاكسارت
|
